Last reviewed · How we verify
NCT03368911
The Effect of Reinforced Endotracheal Tube on Post-operative Hoarseness Undergoing Thyroidectomy
NA trial testing Oral/Nasal Endotracheal Tube, Reinforced (Covidien) in Voice Hoarseness in 140 participants. Completed in 30 November 2018.
30 November 2018
Quick facts
| Lead sponsor | Chonnam National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 1 December 2017 |
| Primary completion | 30 November 2018 |
| Estimated completion | 30 November 2018 |
| Sites | 2 locations across South Korea |
Drugs / interventions tested
- Oral/Nasal Endotracheal Tube, Reinforced (Covidien)
- TaperGuard oral tracheal tube (Covidien)
Conditions studied
- Voice Hoarseness — all drugs for Voice Hoarseness →
- Sore Throat — all drugs for Sore Throat →
- Thyroidectomy — all drugs for Thyroidectomy →
Sponsor
Chonnam National University Hospital
Who can join
Adults 20 to 70, any sex, with Voice Hoarseness or Sore Throat. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is an evaluation of the effect of the reinforced endotracheal tube on post-operative hoarseness and sore throat undergoing thyroidectomy
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03368911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Voice Hoarseness
Currently open trials in the same condition.
- NCT05357222 — Straw Phonation Exercise Program for Pitch Extension · NA · active not recruiting
Other Chonnam National University Hospital trials
Trials by the same sponsor.
- NCT07390461 — Effectiveness of Artificial Intelligence Integrated Mixed Reality-based High-Alert Medications Management Simulation Pro · NA · not yet recruiting
- NCT07482228 — Long-term Clinical Outcomes After Retinal Artery Occlusion · recruiting
- NCT06954714 — Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions · NA · recruiting
- NCT07002164 — Timing of Coronary Angiography in NSTEMI Complicated by Acute HF · NA · recruiting
- NCT06227754 — OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03368911 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chonnam National University Hospital
- Last refreshed: 28 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03368911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing